TITLE

Prevention of systemic embolization associated with treatment of gastric fundal varices

AUTHOR(S)
Matsumoto, Akio; Takimoto, Kengo; Inokuchi, Hideto
PUB. DATE
May 2005
SOURCE
Mayo Clinic Proceedings;May2005, Vol. 80 Issue 5, p705
SOURCE TYPE
Academic Journal
DOC. TYPE
letter
ABSTRACT
Presents a letter to the editor on the prevention of systemic embolization associated with the treatment of gastric fundal varices.
ACCESSION #
17019326

 

Related Articles

  • Is stab with strangulation the fastest way to kill esophageal varices? Toyonaga, Atsushi; Iwao, Tadashi // Journal of Gastroenterology;1999, Vol. 34 Issue 2, p286 

    Editorial. Discusses the use of sclerotherapy in the treatment of bleeding esophageal varices. Description of the technique; Benefits; Disadvantage of ligation therapy; Conclusion.

  • Endoscopic Sclerotherapy. Galambos, John T. // Annals of Internal Medicine;Jun83, Vol. 98 Issue 6, p1009 

    Editorial. Discusses the use of endoscopic sclerotherapy for the treatment or prevention of esophageal varices. Technical aspects of endoscopic sclerotherapy which may affect outcome; Role of prophylactic endoscopic sclerotheraphy; Effectiveness and side effects of endoscopic sclerotherapy.

  • STUDENT'S CORNER: Pathophysiology and treatment of significant bleeding oesophageal varices. LEE, JENNIFER MARGARET // Contemporary Nurse: A Journal for the Australian Nursing Profess;2011, Vol. 39 Issue 2, p221 

    Acute oesophageal variceal haemorrhage is a major cause of death associated with cirrhotic liver disease. Whilst surgical procedures can decrease the risk of recurrent bleeds, pharmacological aids are often used to treat the cause of the varices: portal hypertension. Insertion of a Sengstaken...

  • Endoscopic Sclerotherapy for Bleeding Esophageal Varices: Effects and Complications. Ayres, Steven J.; Goff, John S.; Warren, George H. // Annals of Internal Medicine;Jun83, Vol. 98 Issue 6, p900 

    Presents a study which examined the effects and complications of the use of endoscopic sclerotheraphy for the treatment of bleeding esophageal varices. Methods; Results; Discussion.

  • Terlipressin vs. Octreotide in Bleeding Esophageal Varices. Krag, Aleksander; Bendtsen, Flemming // American Journal of Gastroenterology;Sep2009, Vol. 104 Issue 9, p2351 

    A letter to the editor is presented in response to the article about difference of terlipressin and octreotide in treating esophageal varices bleeding.

  • Complications of Endoscopic Injection Sclerotherapy: A Review. Schuman, Bernard M.; Beckman, John W.; Tedesco, Francis J.; Griffin Jr., Joseph W.; Assad, Ramzi T. // American Journal of Gastroenterology;Sep1987, Vol. 82 Issue 9, p823 

    As endoscopic injection sclerotherapy becomes more widely applied to the treatment of bleeding esophageal varices, an increasing number of complications are being reported. Dysphagia, chest pain, and fever are usually transient and inconsequential but may herald more serious life-threatening...

  • The Role of Sclerotherapy in the Treatment of Esophageal Varices: Personal Experience and a Review of Randomized Trials. Snady, H. // American Journal of Gastroenterology;Sep1987, Vol. 82 Issue 9, p813 

    Describes personal experience and discusses randomized trials regarding the role of sclerotherapy in the treatment of esophageal varices. Disadvantage of using portal-systemic shunt surgery for the treatment of variceal hemorrhage; Variables that may affect the success of endoscopic variceal...

  • Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism. Wei-Dong Gong; Ke Xue; Yuan-Kui Chu; Qing Wang; Wei Yang; Hui Quan; Peng Yang; Zhi-Min Wang; Zhi-Qun Wu // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 10, p19642 

    This study aims to evaluate the therapeutic results of percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization in patients with liver cirrhosis, and to explore the role of this minimally invasive treatment as an alternative to surgery. 25...

  • Hepatic venous pressure gradient is a useful predictor in guiding treatment on prevention of variceal rebleeding in cirrhosis. Gai-Qin Li; Bo Yang; Jun Liu; Guang-Chuan Wang; Hai-Peng Yuan; Jing-Run Zhao; Ji-Yong Liu; Xiao-Pei Li; Chun-Qing Zhang // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 10, p19709 

    Background: The best therapy to prevent esophageal variceal (EV) rebleeding in cirrhotic patients who are non-responsive to pharmacological therapy have not been determined. Aims: To evaluate efficacy of a strategy to assign different treatments according to hepatic vein pressure gradient (HVPG)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics